The enzyme is also thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation.
| Inventor | Institute |
|---|---|
| Ayham Alnabulsi | Vertebrate Antibodies Limited |
| SKU: | 151620 |
|---|---|
| Product description: | Human matrix metalloproteinase 3 (MMP-3) is a member of the matrix metalloproteinases (MMP) family that are peptidases involved in the breakdown of extracellular matrix proteins. MMP-3 degrades fibronectin, laminin, gelatins of type I, III, IV, and V; collagen of type II, III, IV, X, and IX, and proteoglycans. In addition, MMP-3 can also activate other MMPs such as MMP-1, MMP-7, and MMP-9, rendering MMP-3 crucial in connective tissue remodeling. The enzyme is also thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Ovalbumin-conjugated synthetic peptide; CKSLRKLEPELH |
| Myeloma used: | P3X63Ag8.653 |
| Cat. #: | 151620 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell biology;Genetics;Tissue-specific biology |
| Application: | ELISA ; IHC ; IF ; IP ; WB |
| Target: | Human matrix metalloproteinase 3 (MMP-3) |
| Reactivity: | Human |
| Clone: | 1B4 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | Human matrix metalloproteinase 3 (MMP-3) is a member of the matrix metalloproteinases (MMP) family that are peptidases involved in the breakdown of extracellular matrix proteins. MMP-3 degrades fibronectin, laminin, gelatins of type I, III, IV, and V; collagen of type II, III, IV, X, and IX, and proteoglycans. In addition, MMP-3 can also activate other MMPs such as MMP-1, MMP-7, and MMP-9, rendering MMP-3 crucial in connective tissue remodeling. The enzyme is also thought to be involved in wound repair, progression of atherosclerosis, and tumor initiation. |
|---|
| Format: | Liquid |
|---|---|
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -80° C |
| Shipping conditions: | Dry ice |
| References: |
Jeffery et al. 2009. Histopathology. 54(7):820-8. PMID: 19635101. The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Lyall et al. 2006. Clin Cancer Res. 12(4):1184-91. PMID: 16489072. Profiling markers of prognosis in colorectal cancer. Curran et al. 2004. Clin Cancer Res. 10(24):8229-34. PMID: 15623598. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Murray et al. 1998. Gut. 43(6):791-7. PMID: 9824606. Matrix metalloproteinases and their inhibitors in gastric cancer. Murray et al. 1998. J Pathol. 185(3):256-61. PMID: 9771478. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.